Hong Kong’s CR-CP Life Science Fund Leads $22M Series C2 Round In US Biotech Firm

This Data Is Locked!

This area is available only to Subscribers.

American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?